HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Individualized interval shortening in the chemotherapeutic induction treatment of solid tumors (author's transl)].

Abstract
Sequential chemotherapy with vinblastin and bleomycin, as well as adriamycin and cis-platin, was administered to 29 patients with disseminated malignant testicular teratoma. In order to intensify the induction phase, the intervals between drug administrations were individually shortened, with the next course of treatment following directly after the phase of critical leucocyte depression. This method was pursued over four courses of chemotherapy without dose reduction, followed by courses of chemotherapy in a conventional three-weekly rhythm. A response was obtained in 28 patients, 18 of them achieving complete remission. Taking into consideration unfavourable prognostic factors in the treatment group, this result is better than after the same chemotherapy at three-weekly intervals. Induction treatment adapted to leucocyte response carries with it the risk of higher toxicity, but this would seem to be acceptable in view of the improved long-term prognosis. This or similar intensification of the first treatment phase, for a long time used with leukaemias, could also be considered in the management of various chemotherapy-sensitive solid tumours, especially in younger patients.
AuthorsS Seeber, M Higi, N Niederle, C G Schmidt
JournalDeutsche medizinische Wochenschrift (1946) (Dtsch Med Wochenschr) Vol. 106 Issue 51-52 Pg. 1741-4 (Dec 25 1981) ISSN: 0012-0472 [Print] Germany
Vernacular TitleIndividualisierte Intervallverkürzung bei der chemotherapuetischen Induktionsbehandlung solider Tumoren.
PMID6173182 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Bleomycin
  • Vinblastine
  • Doxorubicin
  • Cisplatin
Topics
  • Adolescent
  • Adult
  • Bleomycin (administration & dosage)
  • Cisplatin (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Humans
  • Lung Neoplasms (secondary)
  • Male
  • Middle Aged
  • Teratoma (drug therapy)
  • Testicular Neoplasms (drug therapy)
  • Time Factors
  • Vinblastine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: